The Mesowatch Blog

The Mesowatch Blog is designed to inform and empower victims of asbestos exposure. We cover recent news, lawsuits, trust claims, data reports and medical research involving asbestos-related lung cancer or mesothelioma caused by corporate negligence in the U.S. We are the leading resource for victims of asbestos-related illnesses looking for legal advice and analysis on landmark asbestos cases.

NovoTTF-100LTM and Chemotherapy Approved by FDA

by | Jun 15, 2019

The FDA has approved the NovoTTF-100L system combined with chemotherapy for the treatment of malignant pleural mesothelioma. The combination is the first treatment approved by the FDA for malignant pleural mesothelioma in 15 years. Non-invasive NovoTTF-100L is an...

read more